In hormone receptor (HR) positive and human epidermal growth factor receptor 2 (HER2)-triple-negative breast cancer, the overexpression of CDK4 and 6 can lead to uncontrolled cell proliferation that may evolve into malignant tumors (Zabihi et al. 2023). Here, ERBB2 is linked to cancer.